Gagan Devi
gyanendra Gupta
Abstract
India has earned the
unfortunate distinction of being the
global epicenter for diabetes, with an
alarming projection of 109 million
individuals expected to be afflicted by
the condition by 2035The global
influence of diabetic neuropathy is
significant, with an estimated 132
million individuals affected as of 2010,
constituting roughly 1.9% of the global
populace. Notably, within the diabetic
population, there exists a significantly
heightened prevalence The prevalence of
sensory peripheral neuropathy stands at
60.4%, with an incidence rate of 8.76%.
trend is particularly concerning as
individuals age, with the likelihood of
neuropathy increasing over time.The
pervasive nature of this disease extends
beyond national borders, presenting a
burgeoning global challenge that
profoundly influences daily life. The
repercussions of diabetic neuropathy are
multifaceted, encompassing sensory
impairments, motor dysfunction, and an
array of complications that compromise
overall well-being. Tasks as seemingly
mundane as walking, grasping objects, or
even maintaining balance become
formidable challenges for those affected.
Moreover, the socioeconomic
ramifications of diabetic neuropathy are
substantial, as individuals contend with
reduced productivity, increased
healthcare expenditures, and diminished
quality of life. Furthermore, the burden
extends to caregivers and healthcare
systems, amplifying the strain on
resources and exacerbating healthcare
disparities. Essentially, the widespread
and increasing occurrence of diabetic
neuropathy emphasizes the critical
necessity for comprehensive approaches
focused on preventing, detecting early,
and managing it effectively. Addressing
this multifaceted challenge demands a
concerted global effort, encompassing
research, policy initiatives, public
awareness campaigns, and accessible healthcare services. Only through
collective action can we hope to mitigate
the profound impact of this global health
crisis and alleviate the suffering endured
by millions worldwide
Keywords: Keywords:Diabetes capital,Sensory peripheral neuropathy,Global problem
References
1.Goldmamn’scecil medicine 24 th ed. By Saunders ,an imprint of Elsevier Copyright,2012
edited by Lee Goldman and Andrew I Schafer.
2.Indian Heart Association why south asians facts Web. 30 April 2015.
http://indianheartassociation.org/why-indians-why-south-asians/overview
3.Vos, T (Dec 15, 2012). “Years lived with disability (ylds) for 1160 sequelae of 289 diseases
and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.”
Lancet 380 (9859): 2163–96.
14
4.Battula P et al. International Journal of Research in Medical Sciences Int J Res Med Sci.
2017 Sep;5(9):4066-4071)
5.http://www.ncbi.nlm.nih.gov/pubmed/21274758
6. Pandit Hari Sadasiva Sastri Paradakara editor, Ashtanga Hridaya with the
commentaries Sarvangasundara of Arundatta and Ayurveda Rasayana of Hemadri,
Bhisagacarya; Nidansthan, Chapter 10, Verse 22, Chaukhamba Orientalia, Varanasi,
Reprint -2000, pg 321
7. Aacharya Vaidya Jadavaji Trikamji., editor. Agnivesha, Charaka, Charaka samhita,
Nidana Sthana, Adhyaya. Varanasi: Chaukhamba Sanskrit sansthan. 2nd ed. 47.
Vol. 4. Dridhabala. Varanasi: Chaukhamba Sanskrit sansthan; 1990. 325.
8Taber’s cyclopedic medical dictionary, 20 th edition, f.a.davis company, pg.no. 1462
9.Zeng L, Alongkronrusmee D, van Rijn RM. An integrated perspective on diabetic,
alcoholic, and drug-induced neuropathy, etiology, and treatment in the US. J Pain Res. 2017
Jan 20.
10:219-228.
10.Indian Heart Association why south asians facts Web. 30 April
2015.
11.http://indianheartassociation.org/why-indians-why-south-asians/overview
12.Vos, T (Dec 15, 2012). “Years lived with disability (ylds) for 1160 sequelae of 289
diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease
Study 2010.” Lancet 380 (9859): 2163–96.
13.International Journal of Research in Medical Sciences Battula P et al. Int J Res Med Sci.
2017 Sep;5(9):4066-4071
14. https://emedicine.medscape.com/article/1170337
15.Dorsey RR, Eberhardt MS, Gregg EW, Geiss LS. Control of risk factors among people
with diagnosed diabetes, by lower extremity disease status. Prev Chronic Dis. 2009 Oct.
6(4):A114
16.Tavakkoly-Bazzaz J, Amoli MM, Pravica V, Chandrasecaran R, Boulton AJ, Larijani B.
VEGF gene polymorphism association with diabetic neuropathy. Mol Biol Rep. 2010 Mar
30.
17.Diabetes control and complications trial research group. The effect of intensive treatment
of diabetes on the development and progression of long-term complications in insulin-
dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group.
N Engl J Med. 1993 Sep 30. 329(14):977-86
18.Harati Y. Diabetes and the nervous system. Endocrinal Metab Clin North Am. 1996 Jun.
25(2):325-59.
19.Rutkove SB. A 52-year-old woman with disabling peripheral neuropathy: review of
diabetic polyneuropathy. JAMA. 2009 Oct 7. 302(13):1451-8.
20.Jende JME, Groener JB, Oikonomou D, et al. Diabetic neuropathy differs between type 1
and type 2 diabetes Insights from magnetic resonance neurography. Ann Neurol. 2018 Feb
14.
21. Ryle C, Donaghy M. Non-enzymatic glycation of peripheral nerve proteins in human
diabetics. J Neurol Sci. 1995 Mar. 129(1):62-8
22.Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: The oxidative stress
theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008 Dec. 9(4):301-14
23.American Diabetes Association. Standards of Medical Care in Diabetes—2009. Diabetes
Care. 2009;32:S13-61
Research & Reviews: A Journal of Toxicology
| Volume | |
| Received | February 5, 2024 |
| Accepted | February 9, 2024 |
| Published | March 7, 2024 |